tmao l-carnitine

tmao l-carnitine Characterization of productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery | Microbiome γ-Butyrobetaine Is a Proatherogenic Intermediate

Name: tmao l-carnitine Characterization of productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery | Microbiome γ-Butyrobetaine Is a Proatherogenic Intermediate
Brand: astonvaughan.co.uk
SKU: 22538802663
Price: 25.83 USD
Availability: InStock
Rating: 4.1899 (6 reviews)

Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO ScienceDirect L Carnitine intake and high trimethylamine N oxide plasma levels correlate with low aortic lesions in ApoE transgenic mice expressing CETP Atherosclerosis Intestinal microbiota metabolism of l carnitine, a nutrient in red meat, promotes atherosclerosis Nature Medicine Frontiers Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy

SKU: 22538802663 · From astonvaughan.co.uk

4.2

USD25.83 USD65.83

Pay in 4 interest-free payments of $6.46 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

Infantile nephropathic subtype is the most severe and the most common subtype with early presentation and rapid progression to end-stage kidney disease (ESKD) within the first decade (OMIM # 219800)

PubMed Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition Supports body-composition, lean-mass, and metabolic-risk context